Anna Maria D'URSI | Projects
Anna Maria D'URSI Projects
14 Funded projects
Filter
The effect of nicotine was monitored in neuroblastoma cells SH-SY5Y by analyzing the endo- and exo-metabolome, demonstrating that the metabolomics profile of cells pretreated with nicotine before the addition of Aβ peptide became more similar to that of untreated cells.
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 3.262,64 euro | |
| Project duration | 25 November 2024 - 25 November 2027 | |
| Detail |
⿢Collect, preparation and metabolomic analysis of SMNο7 mice tissue to outline the specific-organ role of SMN gene in SMA pathology⿢Collection and preparation of biofluids (serum, urine, saliva, faeces) from fibromyalgia patients before and after ketogenic or low glycaemic index diet (LOGI)⿢Use of bioinformatics and biostatistics approach for metabolomics data analysis ⿢Integration of metab
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 3.816,90 euro | |
| Project duration | 31 July 2023 - 31 July 2026 | |
| Detail |
Active
Alzheimer's disease (AD), is the most common neurodegenerative disorder of the aging population resulting in progressive cognitive and functional decline. Accumulation of amyloid plaques around neuronal cells is considered a critical pathogenetic event and, in most cases, a hallmark of the pathology. In the attempt to identify anti-AD drug candidates, hundreds of molecules targeting Aß peptides ha
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 12.000,75 euro | |
| Project duration | 25 July 2022 - 25 July 2025 | |
| Detail |
Concluded
The dramatic outcome of the Covid19 pandemic raised the necessity to have a general treatment to limit the evolution to severe infections. The interim result of the first vaccines showing an incomplete efficacy and the new virus variants left a therapeutic space for treatments based on different strategies. Monoclonal antibodies appear to have a promising effect, but because of their high cost the
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | RODRIQUEZ Manuela (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 13.342,37 euro | |
| Project duration | 22 November 2021 - 22 November 2024 | |
| Proroga | 25 Luglio 2025 | |
| Detail |
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 13.450,17 euro | |
| Project duration | 15 February 2021 - 15 February 2024 | |
| Detail |
Studio interdisciplinare, in prospettiva internazionale di lungo periodo, sul rapporto tra ¿Studi di genere e Ricerca scientifica¿ con:-Individuazione del consolidarsi degli stereotipi che hanno portato a una generalizzata scarsa rappresentazione delle donne sia nel mondo accademico che imprenditoriale;-Rapporto tra Lingua/Genere/Professione: diversa connotazione dei sostantivi di professione in
| Department | Dipartimento di Studi Umanistici/DIPSUM | |
| Principal Investigator | MALANDRINO Ornella (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 3.804,26 euro | |
| Project duration | 18 May 2020 - 18 December 2023 | |
| Proroga | 18 dicembre 2023 | |
| Detail |
Mesenchymal stem cells (MSCs) are endowed with huge regenerating potential. [3, 4] According to the International Society for Cellular Therapy (ISCT), they must show adherence to plastic in standard culture conditions. They have to express specific surface markers (= 95%), that are CD105, CD73 and CD90 and at the same time they must lack expression (= 2%) of CD45, CD34, CD14 or CD11b, CD79a or CD1
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 18.288,21 euro | |
| Project duration | 18 May 2020 - 18 May 2023 | |
| Detail |
In the perspective of a theranostic application, the present project is focused on the identification of new substances able to detect Aß peptide at minimal concentration, to be used for early AD diagnosis and to control the formation of ß amyloid fibrils to be used in AD therapy.The project will be developed according to the following points:Identification of Aß-interacting molecules starting
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 12.017,69 euro | |
| Project duration | 11 March 2019 - 10 March 2022 | |
| Detail |
Studio interdisciplinare, in prospettiva internazionale di lungo periodo, sul rapporto tra ¿Costruzioni dei ruoli di Genere¿ e ¿Professioni¿ con:- individuazione del "percorso storico" (date/periodi epocali di mutamento) di specifiche professioni e attività in vari contesti socio-economici e culturali- rapporto tra Lingua/Genere e Professioni (confronto tra italiano e altre lingue)- rappresent
| Department | Dipartimento di Studi Umanistici/DIPSUM | |
| Principal Investigator | MALANDRINO Ornella (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 4.815,38 euro | |
| Project duration | 11 March 2019 - 10 March 2022 | |
| Detail |
Objective of the present project is the design of moleules able to catch potential neurodegenerative biomarkers. Ultimately, these will be used to functionalize ultra¿small Magnetic Nanoparticles (MNPs) for the early and ultrasensitive realization of a diagnostic device based on magnetoresistive sensors, microfluidic device,
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 13.134,49 euro | |
| Project duration | 20 November 2017 - 20 November 2020 | |
| Proroga | 20 febbraio 2021 | |
| Detail |
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 9.892,20 euro | |
| Project duration | 29 July 2016 - 20 September 2018 | |
| Detail |
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | SATURNINO Carmela (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 20.091,94 euro | |
| Project duration | 28 July 2015 - 28 July 2017 | |
| Detail |
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 10.623,13 euro | |
| Project duration | 11 December 2013 - 31 December 2016 | |
| Detail |
| Department | Dipartimento di Farmacia/DIFARMA | |
| Principal Investigator | D'URSI Anna Maria (Project Coordinator) | |
| Funding | University funds | |
| Funders | Università degli Studi di SALERNO | |
| Cost | 11.627,16 euro | |
| Project duration | 7 November 2014 - 6 November 2016 | |
| Detail |
Data source U-GOV dal 1 Gennaio 2013
